← Browse by Condition
Medical Condition

crohn s disease

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 3, Phase 4, Phase 2

ClinicalMetric tracks all active clinical trials for crohn s disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — crohn s disease Clinical Trials

How many clinical trials are currently recruiting for crohn s disease?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for crohn s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for crohn s disease?
crohn s disease research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a crohn s disease clinical trial?
Eligibility criteria for crohn s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
1
Top Sponsors
Takeda 2 trials
Central Hospital, Nancy, France 1 trial
Eli Lilly and Company 1 trial
Sixth Affiliated Hospital, Sun Yat-sen University 1 trial
Universität Duisburg-Essen 1 trial

Recruiting Clinical Trials

NCT05683730
Recruiting
Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease
Enrollment
174 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc...
View Trial →
NCT05509777 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Enrollment
90 pts
Location
United States, Austr...
Sponsor
Eli Lilly and Company
View Trial →
NCT07504510
Recruiting
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
Enrollment
300 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →
NCT06719778
Recruiting
Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease
Enrollment
30 pts
Location
Germany
Sponsor
Universität Duisburg-Essen
View Trial →
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT07403968 Phase 2
Recruiting
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Enrollment
20 pts
Location
United Kingdom
Sponsor
Takeda
View Trial →
NCT07273188 EARLY_Phase 1
Recruiting
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
Enrollment
45 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07102368
Recruiting
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Enrollment
500 pts
Location
Germany
Sponsor
Janssen-Cilag G.m.b.H
View Trial →
NCT01731665
Recruiting
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
Enrollment
2,000 pts
Location
South Korea
Sponsor
Asan Medical Center
View Trial →
NCT06226883 Phase 2
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Enrollment
385 pts
Location
United States, Austr...
Sponsor
Morphic Therapeutic, Inc. (A W...
View Trial →

Related Conditions

ulcerative colitis (2) intestinal fibrosis (1) inflamatory bowel disease (1) intestinal strictures related to crohn s disease (1) inflammatory bowel disease (1) colitis ulcerative (1) epidemiology (1) korea (1) inflammatory bowel diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology